Literature DB >> 7907941

Changes in the expression of sialyl-Lewisx, a hepatic necroinflammation-associated carbohydrate neoantigen, in human hepatocellular carcinomas.

Y Okada1, K Jin-no, H Ikeda, N Sakai, M Sotozono, T Yonei, S Nakanishi, S Moriwaki, T Tsuji.   

Abstract

BACKGROUND: Malignant transformation of cells is associated with the change in their carbohydrate antigens. Sialyl-Lewisx (SLEX) is a necroinflammation-associated carbohydrate antigen (NICA) of liver cells, because it is newly expressed in chronic inflammatory liver diseases. The authors addressed whether this type of carbohydrate antigen shows cancer-associated changes.
METHODS: Expression of SLEX and its related structures was studied immunohistochemically using the well characterized monoclonal antibodies in 13 small and 6 advanced hepatocellular carcinomas (HCC).
RESULTS: SLEX was negative in 7 small HCC, which were well differentiated histologically. Both negative and positive cells were observed in 6 other small HCC. When positive, SLEX was expressed membranously or cytoplasmically. The membrane positive HCC cells were well differentiated. Cytoplasmic expression was observed in the less differentiated cells. The SLEX-negative cells were associated with any degree of differentiation. In six advanced HCC, the expression of SLEX could also be correlated with their histologic differentiation. HCC expressed sialyl-type 2 chain N-acetyllactosamine (2-NAcLc), but not 2-NAcLc, Lewisx, and Lewisy.
CONCLUSIONS: SLEX, a NICA, showed HCC-associated changes that were dependent on the levels of HCC cell differentiation. Suppression and reactivation of alpha 1-3fucosyl-transferase was a possible enzymatic basis for the observed changes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907941     DOI: 10.1002/1097-0142(19940401)73:7<1811::aid-cncr2820730707>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Prognostic and Therapeutic Role of CD15 and CD15s in Cancer.

Authors:  Wojciech Szlasa; Karol Wilk; Klaudia Knecht-Gurwin; Adam Gurwin; Anita Froń; Natalia Sauer; Wojciech Krajewski; Jolanta Saczko; Tomasz Szydełko; Julita Kulbacka; Bartosz Małkiewicz
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

2.  Binding of gastrointestinal tumor cells to endothelial E- and P-selectin adhesion receptors leads to transient down-regulation of sLeX ligands in vitro.

Authors:  Horst Schuldes; Daniel Schleicher; Gottfried Mayer; Bernd H Markus; Jindrich Cinatl; Roman A Blaheta
Journal:  Int J Colorectal Dis       Date:  2003-02-01       Impact factor: 2.571

3.  Hepatitis B virus X protein specially regulates the sialyl lewis a synthesis among glycosylation events for metastasis.

Authors:  Tae-Wook Chung; Seok-Jo Kim; Hee-Jung Choi; Kwon-Ho Song; Un-Ho Jin; Dae-Yeul Yu; Je-Kyung Seong; Jong-Guk Kim; Keuk-Jun Kim; Jeong-Heon Ko; Ki-Tae Ha; Young-Choon Lee; Cheorl-Ho Kim
Journal:  Mol Cancer       Date:  2014-09-25       Impact factor: 27.401

4.  α-1,3-Fucosyltransferase-VII siRNA inhibits the expression of SLex and hepatocarcinoma cell proliferation.

Authors:  Dongsheng Li; Hongzhi Sun; Guang Bai; Wei Wang; Miaomiao Liu; Zhiye Bao; Jingjing Li; Hao Liu
Journal:  Int J Mol Med       Date:  2018-08-31       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.